Comparison of clinical indicators between perimenopausal and postmenopausal women with cardiovascular disease

Read full text
Authors: Jing Wang, Baolin Guo, Haifeng Liu, Zhaoxia Wang, Rutao Wang, Tao Yin, Xiaoqi Liu, Xu Qin, Zhiyong Yin
Cited by: 1
References: 63

Abstract

Background Cardiovascular disease (CVD) prevalence increases with age, particularly in perimenopausal and postmenopausal women due to declining estrogen levels increasing CVD risk. Methods and results From 1248 women, 276 with CVD were screened. Clinical indicators (obesity, blood pressure, BMD, hormones) were compared between perimenopausal and postmenopausal women and across age groups (40-44, 45-49, 50-54). Postmenopausal women had significantly higher BMI, WC/HC, BFP, BFD, SBP, DBP, E2, P, PRL ( p < 0.001), but lower FSH, LH, BMD T1/T2 ( p < 0.001) than perimenopausal women. Significant differences in obesity indicators, BMD, and hormones existed between the 45–49 and 50–54 age groups ( p < 0.05). Conclusions This study elucidates how hormonal changes affect CVD development in women, providing a basis for early screening and intervention strategies.

Fields of Study & Subjects

Menopause: Health Impacts and Treatments Estrogen and related hormone effects Hormonal and reproductive studies

Publication details

Journal / source
Frontiers in Endocrinology
Publisher
Frontiers Media SA
Volume
16
Pages
1681941–1681941
Publication date
13 January 2026
Language
EN